We find significant overexpression of CDH2 across 8 different leukemia types—ALL t(12; 21), ALL t(1; 19), AML normal karyotype, CLL, CML, T-ALL, c-/Pre-B-ALL no t(9; 22), and AML MLL (Figure 2D). This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.